Biodim lets NuPharm access French market

NuPharm has completed a deal to buy French firm Laboratoire Biodim from Weinberg Capital Partners’ Pharma Omnium International, for an undisclosed sum. “This strategic acquisition enables NuPharm to enter France and expand its European footprint,” the group observed, “into its fifth country after Germany, Spain, Italy and Poland.” Created in 2016, Nupharm was the result of combining five companies – Spain’s Qualigen, Laboratorios Lesvi and Inke; Germany’s Neuraxpharm, which also operates in Poland; and Italy’s FB Health – with investment group Apax Partners.